Skip to content

To compare the efficacy of Rasayana Chikitsa with and without Shodhana Karma i.e. Virechana Karma in Psoriasis

Conceptual study of Na Avishuddha Sharirasya Yukto Rasayano Vidhi in perspective of Eka -Kushtha w.s.r. to Psoriasis and its management with Virechana Karma, Amalaki Rasayana and Somraji Taila - w.s.r with special reference

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/104306
Enrollment
40
Registered
2026-02-19
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L409- Psoriasis, unspecified

Interventions

None listed

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with Eka-Kushtha based on Ayurvedic and modern clinical criteria. 2. Participants aged between 18 to 60 years. 3. Mild to moderate cases of Eka-Kushtha. 4. Patients ready to undergo Virechana Karma and follow dietary restrictions. 5. Patients who are willing to give written informed consent to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Patients with severe or widespread erythrodermic, pustular, or psoriatic arthritis. 2. Pregnant and Lactating Women. 3. Patients who are already known cases of diabetes, hypertension, tuberculosis, HIV, hepatitis, chronic renal failure, or malignancies. 4. Conditions like rheumatoid arthritis, SLE, or other systemic autoimmune diseases. 5. Patients who have taken steroids, methotrexate, or biologics within the last 3 months. 6. Patients with severe depression, schizophrenia, or any mental illness affecting compliance.

Design outcomes

Primary

MeasureTime frame
50-95% disease remissionTimepoint: 2 months

Secondary

MeasureTime frame
overall disease remissionTimepoint: 1 year

Countries

India

Contacts

Public ContactDr Sneha Ghosh

R.G.G.P.G. Ayurvedic College and Hospital,Paprola, H.P.

Snehatheghosh@gmail.com919418130228

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026